TYLER MOORE: Open Payments
NPI 1801532106 · REXBURG, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$185 in 10 payments from 5 companies in 2025. Trend: 2023 $144 · 2024 $145 · 2025 $185
Food & beverage: $185
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $100 |
| Novo Nordisk Inc | 2 | $35 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Medtronic, Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $14 |
Products named: VRAYLAR, AIRSUPRA, Ozempic, INCEPTIV, Rybelsus, MOUNJARO.
Industry payments across ID — which companies pay providers there.
